Safety and Efficacy Study of VIS649 for IgA Nephropathy
Clinical trial NCT04287985 · COMPLETED
Trial details
- NCT number
- NCT04287985
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2023-05-19
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.